Related Experiment Videos

Systemic chemotherapy for metastatic colorectal cancer: reasons to combine

Emiliano Calvo¹

¹Oncology Dept, Hospital San Jaime, Alicante, Spain.

Clinical Colorectal Cancer

|December 17, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Phase 1/1b open-label, first-in-human study of HER2×CD3×CD28 trispecific T-cell engager (SAR443216) in participants with R/R HER2-expressing solid tumors.

Journal for immunotherapy of cancer·2026

Vobramitamab duocarmazine, an anti-B7-H3 antibody-drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion.

Cancer·2026

An anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial.

Nature medicine·2026

Tumor-type specific methylation patterns of MTAP in human samples and cell lines.

Clinical epigenetics·2026

Integrating antibody-drug conjugates into solid tumor oncology: Current standards and future directions.

Cancer·2026

Human Absorption, Metabolism, and Excretion (hAME) Mass Balance Studies in Patients With Cancer.

Clinical and translational science·2026

See all related articles